0115 7029 (Pancrelipase 30000 units / 8000 units / 30000 units)
Pill imprint 0115 7029 has been identified as Pancrelipase 30000 units / 8000 units / 30000 units.
Pancrelipase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancrelipase 30000 units / 8000 units / 30000 units is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 0115 7029
- Strength:
- 30000 units / 8000 units / 30000 units
- Color:
- Beige
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
More about pancrelipase
Consumer resources
- Amylase/lipase/protease
- Amylase/lipase/protease delayed-release capsules
- Pancrelipase
- Pancrelipase capsules
- Pancrelipase capsules (enteric-coated)
- More (2) »
- Other brands: Creon, Zenpep, Pancreaze, Pertzye, More (11) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
